Depressive and anxiety disorders in chronic hepatitis C patients: Reliability and validity of the Patient Health Questionnaire

被引:53
作者
Navines, R. [1 ,2 ]
Castellvi, P. [1 ,2 ]
Moreno-Espana, J. [1 ,2 ,3 ]
Gimenez, D. [4 ]
Udina, M. [1 ,2 ,3 ]
Canizares, S. [1 ,2 ]
Diez-Quevedo, C. [5 ]
Valdes, M. [1 ,2 ,3 ]
Sola, R. [4 ]
Martin-Santos, R. [1 ,2 ,3 ]
机构
[1] Univ Barcelona, Hosp Clin, Inst Neurosci, Dept Psychiat,IDIBAPS,CIBERSAM, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin, Inst Neurosci, Dept Psychol,IDIBAPS,CIBERSAM, E-08036 Barcelona, Spain
[3] Univ Barcelona, Dept Psychiat & Clin Psychobiol, E-08036 Barcelona, Spain
[4] Autonomous Univ Barcelona, Liver Unit, Barcelona, Spain
[5] Autonomous Univ Barcelona, Hosp Germans Trias & Pujol, Dept Psychiat, Barcelona, Spain
关键词
Chronic hepatitis C; Depression; Anxiety; PHQ; Screening instrument; Validation; QUALITY-OF-LIFE; DIAGNOSING MENTAL-DISORDERS; INTERFERON-ALPHA; HOSPITAL ANXIETY; SCREENING TOOL; PRIMARY-CARE; VIRUS; VALIDATION; SYMPTOMS; UTILITY;
D O I
10.1016/j.jad.2012.01.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Depression and anxiety in patients with hepatitis C virus (HCV) infection influence their health-related quality of life and their adherence to antiviral treatment. Objective: To study the psychometric properties of the Patient Health Questionnaire (PHQ) as a screening instrument for depression and anxiety in HCV patients. Methods: Criterion validity, using the structured clinical interview for DSM-IV-Axis I (SCID-I) to diagnose depression and anxiety disorders as diagnostic standard, was evaluated for both summed and algorithm-based PHQ in 500 HCV patients. Correlations with quality of life (Short-Form-36 Health Survey; SF-36) and severity of illness (Hospital Anxiety and Depression Scale; HADS) were calculated to assess construct validity. Test-retest reliability and patients' reaction to the PHQ were assessed in 120 HCV patients. Results: Twenty-three percent of patients (N = 114) had a psychiatric disorder (any depressive disorder = 18.2%; major depressive disorder = 6.4%; generalized anxiety disorder = 7.0% and panic disorder = 5.8%). The questionnaire demonstrated good test-retest reliability for any depressive disorder (k = .847), major depressive disorder (k = .784), generalized anxiety disorder (k = .787), panic disorder (k = .848), and for any psychiatric disorder (k = .847). There was good agreement between PHQ and SCID-I diagnoses (for any PHQ disorder. k = .821; overall accuracy = 90.43%. sensitivity = 83.84%; specificity = 97.01%). Patients with any PHQ disorder had higher impairment on the SF-36 (p<.001). HADS depression and anxiety scores showed high correlations with PHQ depression (p<.001) and anxiety (p<.001) scores respectively. PHQ administration was well accepted by 97% of patients. Conclusions: The Spanish version of the PHQ is a reliable, valid, and useful screening instrument to detect depression, generalized anxiety and panic disorders in HCV patients. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 47 条
  • [1] Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students
    Adewuya, Abiodun O.
    ola, B. A. Ola
    O Afolabi, Olusegun
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2006, 96 (1-2) : 89 - 93
  • [2] ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771
  • [3] The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
    Armstrong, Gregory L.
    Wasley, Annemarie
    Simard, Edgar P.
    McQuillan, Geraldine M.
    Kuhnert, Wendi L.
    Alter, Miriam J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (10) : 705 - 714
  • [4] Health-related quality of life in patients with chronic hepatitis B
    Bondini, Silvia
    Kallman, Jillian
    Dan, Amy
    Younoszai, Zahra
    Ramsey, Lolita
    Nader, Fatema
    Younossi, Zobair M.
    [J]. LIVER INTERNATIONAL, 2007, 27 (08) : 1119 - 1125
  • [5] Hepatitis C virus: Virology, diagnosis and management of antiviral therapy
    Chevaliez, Stephane
    Pawlotsky, Jean-Michel
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (17) : 2461 - 2466
  • [6] Depression, anemia and health-related quality of life in chronic hepatitis C
    Dan, AA
    Martin, LM
    Crone, C
    Ong, JP
    Farmer, DW
    Wise, T
    Robbins, SC
    Younossi, ZM
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 (03) : 491 - 498
  • [7] Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C
    Dbouk, Nader
    Arguedas, Miguel R.
    Sheikh, Aasim
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (04) : 1100 - 1106
  • [8] Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review
    Dieperink, E
    Willenbring, M
    Ho, SB
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) : 867 - 876
  • [9] Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients
    Diez-Quevedo, C
    Rangil, T
    Sanchez-Planell, L
    Kroenke, K
    Spitzer, RL
    [J]. PSYCHOSOMATIC MEDICINE, 2001, 63 (04): : 679 - 686
  • [10] Psychiatric symptoms during interferon treatment for hepatitis C: experiences from a tertiary care hepatology centre
    Evon, D. M.
    Verma, A.
    Simpson, K.
    Galanko, J. A.
    Dougherty, K. A.
    Fried, M. W.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (11) : 1071 - 1080